ruptură Livadă Recent p63 as a prognostic marker in gastric Calm Locație ecran
IJMS | Free Full-Text | p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
p63 expression in assessment of bronchioloalveolar proliferations of the lung | Modern Pathology
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect
Regulation of p63 Isoforms by Snail and Slug Transcription Factors in Human Squamous Cell Carcinoma - The American Journal of Pathology
IJMS | Free Full-Text | p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
IJMS | Free Full-Text | p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
p63 expression in cancerous tissues. Strong p63 immunostaining is seen... | Download Scientific Diagram
Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients - Stefansson - 2006 - International Journal of Cancer - Wiley Online Library
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors. - Abstract - Europe PMC
PDF) The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
p63 and p73 in human cancer: defining the network | Oncogene
Ets1 as a marker of malignant potential in gastric carcinoma
Frontiers | p63 Directs Subtype-Specific Gene Expression in HPV+ Head and Neck Squamous Cell Carcinoma
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies | Nature Communications
TTF-1 and p63 expression in small-cell lung carci- | Download Table
P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma - Gynecologic Oncology
A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | SpringerLink